Scholars Central

Conference abstractPublished 3 Oct 2016

A combination of Nottingham prognostic index and IHC4 score predicts pathological complete response of neoadjuvant chemotherapy in estrogen receptor positive breast cancer

Authors: Chang Gong

Sun Yat-Sen University, Guangzhou, China

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Pathologic complete response (pCR) prediction after neoadjuvant chemotherapy (NAC) is important for clinical decision-making in breast cancer. Nottingham prognostic index (NPI) and Immunohistochemical four (IHC4) score are cost-effective prognostic biomarkers. However, whether these factors can predict pCR remains unknown. A new NPI+IHC4 scoring system was built on the combination of NPI and IHC4 score by variable assignment method. A new predictive biomarker named NPI+IHC4 was developed to predict pCR in a study set (n=443) and validated in an external validation set (n=296). Multivariate analysis of variables for a pCR was performed via logistic regression analysis. The ROC curves were employed to test the sensitivity and specificity of variables in predicting pCR and disease-free survival (DFS).In the study set, a lower IHC4 score, NPI and NPI+IHC4 were significantly associated a high pCR rate, multivariable analysis showed tumor size, TNM, NPI and IHC4 score were independent predictors of. NPI+IHC4 showed a better sensitivity and specificity for pCR prediction (AUC 0.699, 95% CI 0.626-0.772) than IHC4 score, NPI, tumor size and TNM stage. In the validation set, NPI+IHC4 had a better predictive value for pCR (AUC 0.665, 95% CI 0.579-0.751) than IHC4 score or NPI alone. In addition, ER+ patients with lower IHC4, NPI and NPI+IHC4 scores had significantly better DFS in both study and validation sets. NPI+IHC4 can predict pCR following NAC and prognosis in ER+ breast cancer. This study provides evidence that incorporating macro-anatomic features and molecular information can improve pCR prediction following NAC.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectOncology & Cancer
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Chang Gong”